US Stock MarketDetailed Quotes
BOLD Boundless Bio
- 3.280
- +0.070+2.18%
Trading Sep 13 12:12 ET
72.99MMarket Cap-1264P/E (TTM)
3.370High3.230Low19.71KVolume3.280Open3.210Pre Close65.21KTurnover0.32%Turnover RatioLossP/E (Static)22.25MShares15.24052wk High0.41P/B20.50MFloat Cap2.85052wk Low--Dividend TTM6.25MShs Float15.240Historical High--Div YieldTTM4.36%Amplitude2.850Historical Low3.308Avg Price1Lot Size
About Boundless Bio Company
Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in San Diego, CA.
Company Profile
SymbolBOLD
Company NameBoundless Bio
Listing DateMar 28, 2024
Issue Price16.00
Founded2018
CEOMr. Zachary D. Hornby
MarketNASDAQ
Employees72
Fiscal Year Ends12-31
Address9880 Campus Point Drive,Suite 120
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-766-9912
Websitehttp://www.boundlessbio.com
Company Executives
- Name
- Position
- Salary
- Matthew R. Patterson
- Chief Executive Officer and Chairman
- --
- Zachary D. Hornby
- President, Chief Executive Officer and Director
- 2.37M
- Dr. Suyash Prasad, M.B.B.S.
- Senior Vice President and Chief Medical Officer
- --
- John T. Gray
- Senior Vice President and Chief Technology Officer
- --
- Dr. Klaus W. Wagner, M.D.,PhD
- Chief Medical Officer
- 996.66K
- Jessica Oien
- Chief Legal Officer and Corporate Secretary
- --
- Neil Abdollahian
- Chief Business Officer
- --
- Thomas P. Soloway
- Principal Accounting Officer, Executive Vice President and Chief Financial Officer
- --
- Natalie C. Holles
- President and Chief Operating Officer
- --
- Eric Mosbrooker
- Senior Vice President and Chief Commercial Officer
- --
- Jami Rubin
- Chief Financial Officer
- --
- Christian Hassig, PhD
- Chief Business Officer
- 903.51K
- Mark A. Meltz
- Senior Vice President and General Counsel
- --
- Dr. Jonathan E. Lim,M.D.
- Chairman of the Board
- 61.17K
- Dr. Thomas J. Schuetz, PhD.
- Independent Director
- --
- Dr. Jakob Loven, PhD
- Independent Director
- --
- Dr. Christine Brennan, PhD
- Independent Director
- --
- Scott W. Morrison
- Independent Director
- --
- Dr. Mark A. Goldberg, M.D.
- Independent Director
- --
- Dr. Fabio Pucci, PhD
- Independent Director
- --
- Jennifer Jarrett
- Independent Director
- --
- Jennifer Lew
- Independent Director
- 66.55K
- Dr. James Christensen, PhD
- Independent Director
- 102.74K
- Julie Anne Smith
- Independent Director
- --
- Dr. Nancy C. Whiting, Pharm.D.
- Independent Director
- 102.74K
- Louis G. Lange, M.D.
- Independent Director
- --
- Kristina M. Burow
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
